±â¸éÁõ : Ãâ½Ã¾à°ú ÆÄÀÌÇÁ¶óÀÎ¾à Æò°¡, ÀÓ»ó½ÃÇè, °æÀï »óȲ
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
»óǰÄÚµå : 1116965
¸®¼­Ä¡»ç : GlobalData
¹ßÇàÀÏ : 2023³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 73 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,495 £Ü 4,934,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,990 £Ü 9,869,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,485 £Ü 14,804,000
PDF (Global License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(ÇØ¿Ü)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

2022³â 16°³ Ãâ½Ã¾à ½ÃÀå¿¡¼­ ±â¸éÁõÀ¸·Î Áø´ÜµÈ À¯º´¿¹´Â 1,600¸¸ ¸íÀ» ³Ñ¾î¼³ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±â¸éÁõ Ä¡·áÁ¦·Î¼­ ÇöÀç 4°³ ÁÖ¿ä Ãâ½Ã¾àÀÌ ÆÇ¸ÅµÇ°í ÀÖ½À´Ï´Ù. ÆÄÀÌÇÁ¶óÀÎ¾à °³¹ßÀº ¼Ò±ØÀûÀ̰í, ´Ü°è III¿¡ 2°³, ´Ü°è II¿¡ 5°³ È常¸ÀÌ ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇè °³¹ßÀº »ó¾÷ ½ºÆù¼­°¡ Áß½ÉÀ¸·Î, ¹Ì±¹ÀÌ ±â¸éÁõ ½ÃÇè ½Ç½ÃÀÇ ÁÖ¿ä ±¹°¡·Î¼­ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ±â¸éÁõ(Narcolepsy) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, Áúȯ »óȲ, Ãâ½Ã¾à¡¤ÆÄÀÌÇÁ¶óÀξࡤÀÓ»ó½ÃÇè Æò°¡, °Å·¡ »óȲ, ½ÃÀå ±â¾÷ µî, ÆÄÀÌÇÁ¶óÀÎ Á¦Ç° ¹× ±â¼ú ¸®ºä, ½ÃÀåÀ» Çü¼º/°ßÀÎÇÏ´Â µ¿Çâ, °æÀï »óȲ µî¿¡ °üÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç °á°ú

Á¦3Àå Áúȯ »óȲ

Á¦4Àå Ãâ½Ã¾à Æò°¡

Á¦5Àå ÆÄÀÌÇÁ¶óÀÎ¾à Æò°¡

Á¦6Àå ÀÓ»ó½ÃÇè Æò°¡

Á¦7Àå °Å·¡ »óȲ

Á¦8Àå »ó¾÷Àû Æò°¡

Á¦9Àå ÇâÈÄ ½ÃÀå Ã˸Å

Á¦10Àå ºÎ·Ï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Abstract

This reports provides a data-driven overview of the current and future competitive landscape in Narcolepsy therapeutics.

Scope

GlobalData's Narcolepsy: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include -

Reasons to Buy

Table of Contents

Table of Contents

1 Preface

2 Key Findings

3 Disease Landscape

4 Marketed Drugs Assessment

5 Pricing and Reimbursement Assessment

6 Pipeline Drugs Assessment

7 Clinical Trials Assessment

8 Deals Landscape

9 Commercial Assessment

10 Future Market Catalysts

11 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â